Candriam SCA’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3M Sell
47,900
-25,411
-35% -$11.9M 0.1% 196
2026
Q1
$29.1M Sell
73,311
-17,301
-19% -$7.82M 0.15% 146
2025
Q4
$42.6M Sell
90,612
-3,027
-3% -$1.34M 0.21% 103
2025
Q3
$46.2M Buy
93,639
+4,221
+5% +$2.39M 0.24% 91
2025
Q2
$45.8M Buy
89,418
+13,051
+17% +$6.08M 0.26% 88
2025
Q1
$32.8M Sell
76,367
-5,758
-7% -$2.8M 0.21% 106
2024
Q4
$39.9M Buy
82,125
+356
+0.4% +$186K 0.23% 89
2024
Q3
$41.4M Buy
81,769
+18,371
+29% +$9.86M 0.24% 91
2024
Q2
$37.7M Sell
63,398
-1,482
-2% -$838K 0.23% 95
2024
Q1
$37.1M Sell
64,880
-22,798
-26% -$12.5M 0.24% 99
2023
Q4
$45.1M Sell
87,678
-5,550
-6% -$2.84M 0.31% 80
2023
Q3
$42.8M Sell
93,228
-26,368
-22% -$11.8M 0.3% 71
2023
Q2
$52.1M Sell
119,596
-66,155
-36% -$26.6M 0.38% 63
2023
Q1
$66M Sell
185,751
-5,108
-3% -$1.82M 0.46% 44
2022
Q4
$60.9M Buy
190,859
+49,795
+35% +$15.6M 0.41% 55
2022
Q3
$43.1M Buy
141,064
+1,320
+0.9% +$447K 0.3% 75
2022
Q2
$42.4M Buy
139,744
+15,834
+13% +$4.78M 0.35% 69
2022
Q1
$41.3M Buy
123,910
+7,007
+6% +$2.19M 0.28% 86
2021
Q4
$43.1M Buy
116,903
+8,341
+8% +$2.81M 0.27% 91
2021
Q3
$32.5M Sell
108,562
-2,419
-2% -$734K 0.22% 108
2021
Q2
$30.6M Buy
110,981
+15,934
+17% +$4.04M 0.21% 112
2021
Q1
$23.7M Sell
95,047
-2
-0% -$508 0.2% 130
2020
Q4
$24.6M Buy
95,049
+3,437
+4% +$793K 0.2% 131
2020
Q3
$19.6M Buy
91,612
+2,052
+2% +$418K 0.18% 136
2020
Q2
$17.5M Buy
89,560
+25,906
+41% +$4.28M 0.18% 136
2020
Q1
$8.66M Buy
63,654
+22
+0% +$3.13K 0.1% 241
2019
Q4
$8.86M Buy
63,632
+55,895
+722% +$7.67M 0.09% 245
2019
Q3
$1.06M Buy
7,737
+581
+8% +$78.6K 0.01% 597
2019
Q2
$917K Buy
+7,156
New +$861K 0.01% 665

Other funds holding SNPS

Candriam SCA's SNPS Position: Q2 2026 in Review

Candriam SCA reduced its Synopsys (SNPS) stake by 35% in Q2 2026, selling an estimated $11.9M and leaving 47,900 shares worth $21.3M. The position accounts for 0.1% of the portfolio, ranked #196.

Candriam SCA first reported a position in SNPS in Q2 2019 and has held it in 29 quarters since. The position peaked at $66M in Q1 2023. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Candriam SCA held 47,900 shares of Synopsys worth $21.3M as of Q2 2026.
  • Candriam SCA sold 25,411 Synopsys shares in Q2 2026, an estimated $11.9M.
  • Synopsys made up 0.1% of Candriam SCA's portfolio in Q2 2026, its #196 holding.
  • Candriam SCA first reported a position in Synopsys in Q2 2019 and has held it in 29 quarters since.
  • Candriam SCA's Synopsys position peaked at $66M in Q1 2023.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.